Background: Recruitment to pediatric randomised controlled trials (RCTs) can be a challenge, with ethical issues surrounding assent and consent. Pediatric RCTs frequently recruit from a smaller pool of patients making adequate recruitment difficult. One factor which influences recruitment and retention in pediatric trials is patient and parent preferences for treatment. Purpose: To systematically review pediatric RCTs reporting treatment preference. Methods: Database searches included: MEDLINE, CINAHL, EMBASE, and COCHRANE.Qualitative or quantitative papers were eligible if they reported: pediatric population, (0–17 years) recruited to an RCT and reported treatment preference for all or some of the participants/parents in any clinical area....
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...
Ensuring parents make an informed decision about their child’s participation in a clinical trial is ...
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...
© 2019 Background: Recruitment to pediatric randomised controlled trials (RCTs) can be a challenge, ...
Background: Randomised controlled trials (RCTs) are recommended as the gold standard in evaluating h...
Background: Studies have shown that many drugs used in children may not have been authorised for use...
Background. In paediatric epilepsy, the evidence of effectiveness of antiseizure treatment is inconc...
Background: Randomised controlled trials (RCTs) are recommended as the gold standard in evaluating h...
OBJECTIVES: To investigate recruitment processes across a range of clinical trials and from the pers...
Background: Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating...
Background Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating...
Background Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating ...
Abstract Background Genuine uncertainty on superiority of one intervention over the other is called ...
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...
Background Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating ...
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...
Ensuring parents make an informed decision about their child’s participation in a clinical trial is ...
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...
© 2019 Background: Recruitment to pediatric randomised controlled trials (RCTs) can be a challenge, ...
Background: Randomised controlled trials (RCTs) are recommended as the gold standard in evaluating h...
Background: Studies have shown that many drugs used in children may not have been authorised for use...
Background. In paediatric epilepsy, the evidence of effectiveness of antiseizure treatment is inconc...
Background: Randomised controlled trials (RCTs) are recommended as the gold standard in evaluating h...
OBJECTIVES: To investigate recruitment processes across a range of clinical trials and from the pers...
Background: Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating...
Background Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating...
Background Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating ...
Abstract Background Genuine uncertainty on superiority of one intervention over the other is called ...
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...
Background Randomised controlled trials (RCTs) are recommended as the ‘gold standard’ in evaluating ...
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...
Ensuring parents make an informed decision about their child’s participation in a clinical trial is ...
Enrollment of children into pediatric clinical trials remains challenging. More effective strategies...